v3.22.2.2
Financial Instruments and Fair Value Measurements - Schedule of Available-for-sale Securities and Equity Securities (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cost $ 10,422 $ 5,249
Estimated Fair Value 10,422 5,249
Cash equivalents 10,001 5,003
Restricted cash 175  
Other assets 246 246
Total cash equivalents, restricted cash, and other assets 10,422 5,249
Money market funds    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cost 255 5,003
Estimated Fair Value 255 5,003
U.S. treasury securities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cost 9,921  
Estimated Fair Value 9,921  
Equity securities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cost [1] 246 246
Estimated Fair Value [1] $ 246 $ 246
[1] The Company’s equity securities included in other assets consisted of its investment in a privately held company. The Company recognizes its private company equity securities at cost minus impairments, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. No such impairments or changes were noted for any period presented.